Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of Hepatic Steatosis on Entecavir Efficacy in Chronic Hepatitis B
NCT01148576Phase 4Unknown
- Sponsor
- Zhejiang University
- Start
- Jun 2010
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of entecavir in Chronic Hepatitis B (CHB) (4 arms), sponsored by Zhejiang University. Primary endpoint: Anti-viral effect of entecavir at 12 months. Status: unknown.
02
Drugs
entecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01148576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01148576.